Literature DB >> 26063800

Promoters of Human Cosmc and T-synthase Genes Are Similar in Structure, Yet Different in Epigenetic Regulation.

Junwei Zeng1, Rongjuan Mi1, Yingchun Wang1, Yujing Li2, Li Lin2, Bing Yao2, Lina Song1, Irma van Die3, Arlene B Chapman4, Richard D Cummings1, Peng Jin2, Tongzhong Ju5.   

Abstract

The T-synthase (core 1 β3-galactosyltransferase) and its molecular chaperone Cosmc regulate the biosynthesis of mucin type O-glycans on glycoproteins, and evidence suggests that both T-synthase and Cosmc are transcriptionally suppressed in several human diseases, although the transcriptional regulation of these two genes is not understood. Here, we characterized the promoters essential for human Cosmc and T-synthase transcription. The upstream regions of the genes lack a conventional TATA box but contain CpG islands, cCpG-I and cCpG-II for Cosmc and tCpG for T-synthase. Using luciferase reporter assays, site-directed mutagenesis, ChIP assays, and mithramycin A treatment, we identified the core promoters within cCpG-II and tCpG, which contain two binding sites for Krüppel-like transcription factors, including SP1/SP3, respectively. Methylome analysis of Tn4 B cells, which harbor a silenced Cosmc, confirmed the hypermethylation of the Cosmc core promoter but not for T-synthase. These results demonstrate that Cosmc and T-synthase are transcriptionally regulated at a basal level by the specificity protein/Krüppel-like transcription factor family of members, which explains their ubiquitous and coordinated expression, and also indicate that they are differentially epigenetically regulated beyond X chromosome imprinting. These results are important in understanding the regulation of these genes that have roles in human diseases, such as IgA nephropathy and cancer.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Cosmc; DNA methylation; IgA nephropathy; T-synthase; gene regulation; glycosylation; promoter; transcription

Mesh:

Substances:

Year:  2015        PMID: 26063800      PMCID: PMC4521027          DOI: 10.1074/jbc.M115.654244

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  77 in total

1.  Aberrantly glycosylated IgA1 in glomerular immune deposits of IgA nephropathy.

Authors:  Konstantinos Giannakakis; Sandro Feriozzi; Marie Perez; Tullio Faraggiana; Andrea Onetti Muda
Journal:  J Am Soc Nephrol       Date:  2007-10-31       Impact factor: 10.121

2.  Initiation of protein O glycosylation by the polypeptide GalNAcT-1 in vascular biology and humoral immunity.

Authors:  Mari Tenno; Kazuaki Ohtsubo; Fred K Hagen; David Ditto; Alexander Zarbock; Patrick Schaerli; Ulrich H von Andrian; Klaus Ley; Dzung Le; Lawrence A Tabak; Jamey D Marth
Journal:  Mol Cell Biol       Date:  2007-10-08       Impact factor: 4.272

Review 3.  The aureolic acid family of antitumor compounds: structure, mode of action, biosynthesis, and novel derivatives.

Authors:  Felipe Lombó; Nuria Menéndez; José A Salas; Carmen Méndez
Journal:  Appl Microbiol Biotechnol       Date:  2006-09-30       Impact factor: 4.813

4.  Protein glycosylation: chaperone mutation in Tn syndrome.

Authors:  Tongzhong Ju; Richard D Cummings
Journal:  Nature       Date:  2005-10-27       Impact factor: 49.962

5.  NFkappaB-p65 dependent transcriptional regulation of glycosyltransferases in human colon adenocarcinoma HT-29 by stimulation with tumor necrosis factor alpha.

Authors:  Koji Higai; Saki Ishihara; Kojiro Matsumoto
Journal:  Biol Pharm Bull       Date:  2006-12       Impact factor: 2.233

6.  A mutant chaperone converts a wild-type protein into a tumor-specific antigen.

Authors:  Andrea Schietinger; Mary Philip; Barbara A Yoshida; Parastoo Azadi; Hui Liu; Stephen C Meredith; Hans Schreiber
Journal:  Science       Date:  2006-10-13       Impact factor: 47.728

7.  Peripheral B lymphocyte beta1,3-galactosyltransferase and chaperone expression in immunoglobulin A nephropathy.

Authors:  W Qin; Q Zhou; L-C Yang; Z Li; B-H Su; H Luo; J-M Fan
Journal:  J Intern Med       Date:  2005-11       Impact factor: 8.989

8.  Sequential action of Ets-1 and Sp1 in the activation of the human beta-1,4-galactosyltransferase V gene involved in abnormal glycosylation characteristic of cancer cells.

Authors:  Takeshi Sato; Kiyoshi Furukawa
Journal:  J Biol Chem       Date:  2007-07-26       Impact factor: 5.157

9.  Control of core 2 beta1,6 N-acetylglucosaminyltransferase-I transcription by Sp1 in lymphocytes and epithelial cells.

Authors:  V Rebecca Falkenberg; Nevis Fregien
Journal:  Glycoconj J       Date:  2007-05-26       Impact factor: 2.916

10.  Structural changes in TAF4b-TFIID correlate with promoter selectivity.

Authors:  Wei-Li Liu; Robert A Coleman; Patricia Grob; David S King; Laurence Florens; Michael P Washburn; Kenneth G Geles; Joyce L Yang; Vincent Ramey; Eva Nogales; Robert Tjian
Journal:  Mol Cell       Date:  2008-01-18       Impact factor: 17.970

View more
  9 in total

1.  Galactosylation of IgA1 Is Associated with Common Variation in C1GALT1.

Authors:  Daniel P Gale; Karen Molyneux; David Wimbury; Patricia Higgins; Adam P Levine; Ben Caplin; Anna Ferlin; Peiran Yin; Christopher P Nelson; Horia Stanescu; Nilesh J Samani; Robert Kleta; Xueqing Yu; Jonathan Barratt
Journal:  J Am Soc Nephrol       Date:  2017-02-16       Impact factor: 10.121

Review 2.  Epigenetic Bases of Aberrant Glycosylation in Cancer.

Authors:  Fabio Dall'Olio; Marco Trinchera
Journal:  Int J Mol Sci       Date:  2017-05-06       Impact factor: 5.923

3.  COSMC mutations reduce T-synthase activity in advanced Alzheimer's disease.

Authors:  Seema Gollamudi; Rukmani Lekhraj; Shirin Lalezari; Parviz Lalezari
Journal:  Alzheimers Dement (N Y)       Date:  2020-06-26

4.  Differential expression of Cosmc, T-synthase and mucins in Tn-positive colorectal cancers.

Authors:  Xiaodong Sun; Tongzhong Ju; Richard D Cummings
Journal:  BMC Cancer       Date:  2018-08-16       Impact factor: 4.430

5.  A Systematic Review on the Implications of O-linked Glycan Branching and Truncating Enzymes on Cancer Progression and Metastasis.

Authors:  Rohitesh Gupta; Frank Leon; Sanchita Rauth; Surinder K Batra; Moorthy P Ponnusamy
Journal:  Cells       Date:  2020-02-14       Impact factor: 6.600

6.  Demethylation of the Cosmc Promoter Alleviates the Progression of Breast Cancer Through Downregulation of the Tn and Sialyl-Tn Antigens.

Authors:  Feng Xu; Dong Wang; JianXiu Cui; Jie Li; Hongchuan Jiang
Journal:  Cancer Manag Res       Date:  2020-02-11       Impact factor: 3.989

7.  Cosmc overexpression enhances malignancies in human colon cancer.

Authors:  Tianbo Gao; Tan Du; Xin Hu; Xichen Dong; Lina Li; Yakun Wang; Jian Liu; Lijie Liu; Tao Gu; Tao Wen
Journal:  J Cell Mol Med       Date:  2019-10-21       Impact factor: 5.310

Review 8.  C1GALT1 in health and disease.

Authors:  Xiaojie Sun; Mengru Zhan; Xun Sun; Wanqi Liu; Xiangwei Meng
Journal:  Oncol Lett       Date:  2021-06-06       Impact factor: 2.967

9.  Inhibition of STAT3 Signaling Reduces IgA1 Autoantigen Production in IgA Nephropathy.

Authors:  Koshi Yamada; Zhi-Qiang Huang; Milan Raska; Colin Reily; Joshua C Anderson; Hitoshi Suzuki; Hiroyuki Ueda; Zina Moldoveanu; Krzysztof Kiryluk; Yusuke Suzuki; Robert J Wyatt; Yasuhiko Tomino; Ali G Gharavi; Amy Weinmann; Bruce A Julian; Christopher D Willey; Jan Novak
Journal:  Kidney Int Rep       Date:  2017-07-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.